Although GLV intake is negatively correlated with NAFLD in normal/overweight individuals, obesity-related metabolic complications such as hyperlipidemia and insulin resistance may significantly increase liver lipids, resulting in decreased insulin sensitivity. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.